1. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- Author
-
Chloe Yuk-Kiu Fung, Vincent Wai-Sun Wong, Jenny L. Limquiaco, Jasmine Ka-Lei Chan, Henry Lik-Yuen Chan, Cheuk-Man Yu, Hiu-Wan Lam, Chelsia Tsz-Yan Kwan, Grace Lai-Hung Wong, Zoe Hoi-Yi Chang, Angel Mei-Ling Chim, and Judy Ching-Lam Yeung
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Coronary Angiography ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Non-alcoholic Fatty Liver Disease ,Internal medicine ,Nonalcoholic fatty liver disease ,medicine ,Humans ,Mass Screening ,Myocardial infarction ,Prospective Studies ,Prospective cohort study ,Mass screening ,Aged ,Ultrasonography ,Hepatology ,business.industry ,Fatty liver ,Coronary Stenosis ,nutritional and metabolic diseases ,Percutaneous coronary intervention ,Middle Aged ,medicine.disease ,digestive system diseases ,Surgery ,Coronary arteries ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Hong Kong ,030211 gastroenterology & hepatology ,Female ,business - Abstract
There is ongoing debate on whether screening for nonalcoholic fatty liver disease (NAFLD) is worthwhile in high-risk groups. Because of shared risk factors, NAFLD is highly prevalent in patients with coronary artery disease. We aimed to test the hypothesis that NAFLD screening in patients requiring coronary angiogram would identify high-risk patients and predict long-term clinical outcomes. This was a prospective cohort study. NAFLD screening was performed by abdominal ultrasonography before coronary angiogram in 612 consecutive patients. At baseline, 356 (58.2%) patients had NAFLD. NAFLD patients, compared with those without, were more likely to have >50% stenosis in one or more coronary arteries (84.6% vs. 64.1%; P
- Published
- 2015